-

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cerence Inc. (CRNC) on Behalf of Investors

Shareholders with $400,000 losses or more are encouraged to contact the firm

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Cerence Inc. (“Cerence” or the “Company”) (NASDAQ: CRNC) investors concerning the Company’s possible violations of federal securities laws.

On November 22, 2021, before the markets opened, Cerence announced that it expected fiscal 2022 revenue “to be in the range of $400M to $425M,” which was well below analysts’ expectations.

On this news, Cerence’s stock fell $21.47, 0r 20.6%, to close at $82.59 per share on November 22, 2021, thereby injuring investors.

Then, on December 15, 2021, Cerence announced that its Chief Executive Office (“CEO”) had abruptly resigned.

On this news, Cerence’s stock fell $8.88, or 11.4%, to close at $69.20 per share on December 15, 2021.

Then, on February 7, 2022, the Company issued its first quarter 2022 financial results and revised its full year 2022 guidance, expecting “revenue to be in the range of $365 million to $385 million because the “conversion from bookings to revenue will take longer than expected.” Cerence also withdrew its closely watched guidance for fiscal year 2024. Furthermore, the Company also announced that its Chief Financial Officer would be retiring.

On this news, Cerence’s stock fell $19.97, or 31.4%, to close at $43.61 per share, thereby injuring investors further.

If you purchased Cerence securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Law Offices of Howard G. Smith

NASDAQ:CRNC

Release Versions

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

CoreWeave, Inc. (CRWV) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of CoreWeave, Inc. (“CoreWeave” or the “Company”) (NASDAQ: CRWV) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN COREWEAVE, INC. (CRWV), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email a...

Law Offices of Howard G. Smith Encourages Bath & Body Works, Inc. (BBWI) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Bath & Body Works, Inc. (“Bath & Body Works” or the “Company”) (NYSE: BBWI) securities between June 4, 2024 and November 19, 2025, inclusive (the “Class Period”). Bath & Body Works investors have until March 16, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BATH & BODY WORKS, INC. (BBWI), CO...

Law Offices of Howard G. Smith Encourages Ardent Health, Inc. (ARDT) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). Ardent investors have until March 9, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ARDENT HEALTH, INC. (ARDT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PA...
Back to Newsroom